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CASE REPORT
Elastosis Perforans Serpiginosa
Si-Hyung Lee, Yuri Choi, Soo-Chan Kim
Department of Dermatology, Gangnam Severance Hospital, The Cutaneous Biology Research Institute, Yonsei University College of 
Medicine, Seoul, Korea
Elastosis perforans serpiginosa is a rare skin disease 
characterized by transepidermal elimination of abnormal 
elastic fibers. This condition classically presents as small 
papules arranged in serpiginous or annular patterns on the 
neck, face, arms, or other flexural areas. While these lesions 
may spontaneously resolve, they often persist for longer 
periods of time. Though numerous treatment modalities 
have been described in the literature, most are not very 
effective. A 35-year-old man presented to Gangnam 
Severance Hospital with a 2-year history of skin eruptions on 
his neck, which were refractory to topical antifungal or 
steroid treatment. On examination, the patient showed 
multiple crusted and erythematous papules arranged in an 
annular pattern with central clearing. A biopsy specimen 
revealed acanthosis with notable transepidermal elimina-
tion of nuclear debris and eosinophilic degenerated elastic 
fibers from the dermis via an epidermal channel. Ver-
hoeff-van Gieson staining showed dense clumps of altered 
elastic fibers in the papillary dermis. Based on these findings, 
a diagnosis of elastosis perforans serpisinosa was made. 
Treatment with topical 0.05% tretinoin application for 6 
months resulted in no improvement. (Ann Dermatol 26(1) 103
∼106, 2014)
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INTRODUCTION
Elastosis perforans serpiginosa (EPS) is a rare skin condition 
characterized by hyperkeratotic papules, transepidermal 
elimination of abnormal elastic fibers, and focal dermal 
elastosis. Since it was first described by Lutz in 1953, EPS is 
one of four classic primary perforating disorders along with 
reactive perforating collagenosis, perforating folliculitis, 
and Kyrle disease1. To date, four cases of EPS have been 
reported in the Korean literature (Table 1)2-5. We report an 
additional case of this rare cutaneous condition and review 
EPS cases described in the Korean literature.
CASE REPORT 
A 35-year-old healthy man visited Gangnam Severance 
Hospital with hyperkeratotic papules on his anterior neck. 
These papules first appeared 2 years ago and slowly 
increased in number. Over time, the skin lesions had 
spread peripherally with some central clearing. The 
patient stated that the skin lesions had developed after a 
skin injury. Previous treatments with topical antifungal 
and topical steroid were ineffective. The patient’s medical 
and family history was also negative for EPS or any other 
connective tissue diseases. On examination, multiple 
crusted erythematous papules (2 to 5 mm in size) were 
arranged in an annular and serpiginous pattern (Fig. 1). A 
potassium hydroxide preparation obtained from the skin 
lesion was negative for fungal elements. A punch biopsy 
specimen revealed focal epidermal hyperplasia with the 
formation of a narrow vertical transepidermal channel 
containing nuclear debris and eosinophilic degenerated 
elastic fibers (Fig. 2A). The amount and thickness of the 
elastic fibers in the papillary dermis had increased 
markedly. It looked like entering the canals toward the 
outside of the skin (Fig. 2B). The papillary dermis and 
superficial reticular dermis were infiltrated by numerous 
inflammatory cells, including lymphocytes and histiocytes 
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Table 1. A summary of the 5 cases of elastosis perforance serpiginosa reported in the Korean literature including our case
Authors 
(year)
Sex/age 
(yr)
Age of 
onset (yr) Site Associated disease Treatment Progression
Lee et al.2 
(1985)
Male/25 21∼22 Neck Not stated Not stated Not stated
Seo et al.3 
(1986)
Female/24 23 Neck Pseudoxanthoma elasticum Not stated Spread to periphery with 
central clearing after 6 months
Nho et al.4 
(1987)
Male/27 26 Neck Pseudoxanthoma elasticum Dry ice Transiently improved
Na et al.5
(2010)
Male/34 33 Neck Wilson’s disease
Cutis laxa
CO2 laser and 
topical tretinoin 
Partial regression
Our case
(2011)
Male/35 32 Neck Not stated Topical tretinoin Not improved
Fig. 1. Crusted erythematous papules (2∼5 mm in size) arranged 
in an annular pattern.
(Fig. 2C). Verhoeff-van Gieson staining showed a 
markedly increased number of altered elastic fibers 
forming dense clumps in the upper dermis (Fig. 2D). 
Gomori methenamine silver stain and D-PAS stain were 
both negative for fungal elements. A diagnosis of EPS was 
made based on these clinical and histopathological 
findings. Despite treatment with topical 0.05% tretinoin 
nightly for 6 months, no improvement was observed. 
DISCUSSION
Perforating diseases are histologically characterized by 
transepidermal elimination of dermal substances. Elastic 
fibers perforate through the epidermis in patients with 
EPS. Table 1 summarizes the clinical data from four cases 
of EPS in the Korean literature in addition to our case. EPS 
is more commonly reported in men and usually occurs 
during childhood or early adulthood1. The data from the 
five Korean patients with EPS further support these 
findings: four of these individuals were men and all first 
presented with skin lesions in their early 30s; three of 
them reported that their lesions first appeared in their 20s. 
Familial cases of EPS have also been reported, with the 
mode of inheritance suggested to be autosomal dominant 
with variable trait expressivity6,7. 
EPS lesions are classically keratotic papules sized 2 to 5 
mm and arranged in a serpiginous or annular pattern on 
the neck, face, arms, and/or other flexural areas. All five 
Korean patients including our patient presented with skin 
lesions on the neck, the most frequently affected EPS site. 
The most prominent histopathological findings in patients 
with EPS are localized segments of hyperplastic epidermis 
where basophilic nuclear debris and brightly eosinophilic 
fragmented elastic fibers are being eliminated through 
transepidermal channels that extend upward from the 
dermis in straight or corkscrew patterns1. In addition to a 
marked increase in the amount and thickness of papillary 
dermal elastic tissue, a chronic inflammatory infiltrate 
containing lymphocytes, macrophages, or multinucleated 
giant cells may be present in the dermis at the sites of 
perforation. Accordingly, Verhoeff-van Gieson staining is 
often helpful in diagnosing EPS.
While the exact pathogenic process of EPS remains 
unknown, associations with various underlying systemic 
conditions and connective tissue disorders have been re-
ported in the literature, including Down’s syndrome, osteo-
genesis imperfecta, scleroderma, acrogeria, Ehlers-Danlos 
syndrome type IV (vascular type), Marfan syndrome, Roth-
mund-Thomson syndrome, cutis laxa, diabetes mellitus, 
perforating folliculitis, and chronic renal failure8,9. How-
ever, it remains unclear whether the relationship between 
these conditions and EPS is causal or coincidental, as EPS 
also commonly occurs in individuals without any 
underlying disease. Notably, two of the five reported 
Korean patients with EPS had comorbid pseudoxanthoma 
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Fig. 2. (A) Focal epidermal hyperplasia with the formation of narrow vertical transepidermal channels (H&E, ×40). (B) Nuclear debris 
and eosinophilic-degenerated elastic fibers present in multiple channel lumens (H&E, ×400). (C) An inflammatory cell infiltrate 
consisting of lymphocytes and histiocytes was present in the papillary and superficial reticular dermis (H&E, ×400). (D) Many dense 
clumps consisting of altered elastic fibers in the upper dermis (Verhoeff-van Gieson stain, ×200).
elasticum. Isolated reports also indicate a possible 
association between EPS and Wilson’s disease and cysti-
nuria, particularly in patients on long-term penicillamine 
therapy5,10-12. Such a case of EPS associated with penicilla-
mine therapy was reported in the Korean literature5. In 
these cases, elastin synthesis may be affected either 
directly by penicillamine or via a localized copper defi-
ciency, ultimately inducing the production of abnormal 
elastic fibers that are transepidermally eliminated from the 
dermis. In cases of EPS associated with penicillamine 
therapy, the characteristic skin lesions typically develop 
within the first year of treatment and can be histologically 
distinguished from the other forms of EPS by the presence 
of calcium deposits in transepidermal elastic fibers7.
While calcinosis cutis, granuloma annulare, Tinea corporis, 
annular sarcoidosis, and porokeratosis of Mibelli may pre-
sent with clinically similar features, these disorders are 
easily distinguished by histological examination. More-
over, even though transepidermal elimination can occur 
in any of the three other perforating diseases, the elastic 
tissue changes present in EPS are virtually pathogno-
monic. 
Although lesions may spontaneously resolve, they often 
persist for longer periods. Numerous treatment modalities 
have been described, including dry ice8, cellophane tape 
stripping8,13, electrodessication and curettage14, cryothe-
rapy13-15, intralesional and topical corticosteroid the-
rapy15,16, topical calcipotriol14, topical tretinoin14,15,17, oral 
isotretinoin14,15, topical tazarotene15, topical imiquimod18, 
topical glycolic or salicylic acid therapy14,17, narrow band 
ultraviolet B radiation14, pulsed dye laser, Er:YAG laser16, 
and carbon dioxide laser therapy15,16. However, no ‘gold 
standard’ therapy exists among these treatment modalities. 
Treatment with topical tretinoin including topical 0.25% 
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tretinoin gel14,15, topical 0.1% tretinoin cream15, and topi-
cal 0.05% tretinoin solution15 nightly for about 2 months 
fails to improve the appearance of these lesions. Laser 
treatment, including carbon dioxide laser and Er:YAG 
laser, are reported to induce complete clearing of EPS 
lesions, but another report showed only mild improve-
ment of EPS lesions and subtle atrophic scarring after 
carbon dioxide laser treatment16. The pinhole method 
using a carbon dioxide laser showed complete clearing 
without post-treatment scarring19. Topical imiquimod and 
topical tazarotene therapy is reported to improve EPS skin 
lesions15,18. However, further studies are needed to 
evaluate the effectiveness of such topical therapy for trea-
ting EPS. In addition, discontinuing penicillamine therapy 
does not guarantee preventing further development of EPS 
lesions in patients undergoing penicillamine therapy15,20. 
In our case, we chose treatment with topical 0.05% tre-
tinoin nightly, but after 6 months of treatment the patient 
did not show any improvement. 
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